연구동향 분석

MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection

이기명 윤준기 김영배 이다근 김영철 2015년

논문상세정보
인용/피인용
' MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 내과학
  • early gastric cancer
  • metamplification
  • metastasis
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
1,570 0

0.0%

' MET-Amplified Intramucosal Gastric Cancer Widely Metastatic after Complete Endoscopic Submucosal Dissection' 의 참고문헌

  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer(ToGA) : a phase 3, open-label, randomised controlled trial
    Bang YJ Lancet 376 : 687 ~ 697 [2010]
  • Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
    Bang YJ Lancet 376 687-697 [2010]
  • Risk factors for lymph node metastasis from intramucosal gastric carcinoma
    Yamao T Cancer 77 : 602 ~ 606 [1996]
  • Risk factors for lymph node metastasis from intramucosal gastric carcinoma
    Yamao T Cancer 77 602-606 [1996]
  • Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection
    Oh HS Gastric Cancer 17 : 402 ~ 411 [2014]
  • Prognostic implications of EGFR and HER-2 alteration assessed by immunohistochemistry and silver in situ hybridization in gastric cancer patients following curative resection
    Oh HS Gastric Cancer 17 402-411 [2014]
  • Metastasizing intramucosal gastric carcinomas : well differentiated type and proliferative activity using proliferative cell nuclear antigen and Ki-67
    Oya M Cancer 75 : 926 ~ 935 [1995]
  • Metastasizing intramucosal gastric carcinomas : well differentiated type and proliferative activity using proliferative cell nuclear antigen and Ki-67
    Oya M Cancer 75 926-935 [1995]
  • MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib
    Lennerz JK J Clin Oncol 29 : 4803 ~ 4810 [2011]
  • MET amplification identifies a small and aggressive subgroup of esophagogastric adenocarcinoma with evidence of responsiveness to crizotinib
    Lennerz JK J Clin Oncol 29 4803-4810 [2011]
  • Impact of MET amplification on gastric cancer : possible roles as a novel prognostic marker and a potential therapeutic target
    Lee J Oncol Rep 25 : 1517 ~ 1524 [2011]
  • Impact of MET amplification on gastric cancer : possible roles as a novel prognostic marker and a potential therapeutic target
    Lee J Oncol Rep 25 1517-1524 [2011]
  • Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
    Shi J BMC Cancer 12 : 50 ~ [2012]
  • Highly frequent PIK3CA amplification is associated with poor prognosis in gastric cancer
    Shi J BMC Cancer 12 50- [2012]
  • Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer
    Graziano F J Clin Oncol 29 : 4789 ~ 4795 [2011]
  • Genetic activation of the MET pathway and prognosis of patients with high-risk, radically resected gastric cancer
    Graziano F J Clin Oncol 29 4789-4795 [2011]
  • Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
    Jung EJ Hum Pathol 43 : 1559 ~ 1566 [2012]
  • Fibroblast growth factor receptor 2 gene amplification status and its clinicopathologic significance in gastric carcinoma
    Jung EJ Hum Pathol 43 1559-1566 [2012]
  • Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor
    Kakushima N J Gastroenterol 38 : 1176 ~ 1180 [2003]
  • Early gastric cancer with Krukenberg tumor and review of cases of intramucosal gastric cancers with Krukenberg tumor
    Kakushima N J Gastroenterol 38 1176-1180 [2003]
  • Clinicopathological features of mucosal carcinoma of the stomach with lymph node metastasis in eleven patients
    Korenaga D Br J Surg 73 : 431 ~ 433 [1986]
  • Clinicopathological features of mucosal carcinoma of the stomach with lymph node metastasis in eleven patients
    Korenaga D Br J Surg 73 431-433 [1986]
  • Characteristics of intramucosal gastric carcinoma with lymph node metastatic disease
    Song SY Histopathology 44 : 437 ~ 444 [2004]
  • Characteristics of intramucosal gastric carcinoma with lymph node metastatic disease
    Song SY Histopathology 44 437-444 [2004]
  • Cancer therapy: can the challenge be MET?
    Corso S Trends Mol Med 11 : 284 ~ 292 [2005]
  • Cancer therapy: can the challenge be MET?
    Corso S Trends Mol Med 11 284-292 [2005]
  • A rare case of histologically mixed-type intramucosal gastric cancer accompanied by nodal recurrence and liver metastasis after endoscopic submucosal dissection
    Hanaoka N Gastrointest Endosc 69 (3 Pt 1) : 588 ~ 590 [2009]
  • A rare case of histologically mixed-type intramucosal gastric cancer accompanied by nodal recurrence and liver metastasis after endoscopic submucosal dissection
    Hanaoka N Gastrointest Endosc 69 3 Pt 1 588-590 [2009]
  • A clinicopathologic variant of intramucosal early gastric cancer with widespread dissemination : report of three cases
    Angeles-Angeles A J Clin Gastroenterol 27 : 173 ~ 177 [1998]
  • A clinicopathologic variant of intramucosal early gastric cancer with widespread dissemination : report of three cases
    Angeles-Angeles A J Clin Gastroenterol 27 173-177 [1998]